The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Shares rise as Avis takeover stokes M&A excitement

Tue, 14th Jun 2011 08:32

London's leading share index is posting strong decent growth this morning in contrast to recent sluggishness, but the excitement is in the FTSE 250 with Avis Europe soaring on news the Avis car hire brand is set to return to single ownership after US operator Avis Budget launched an agreed bid.Avis Budget will offer 315p cash for each Avis Europe share in a deal that values the UK listed company at around £636m. The mid-market price of Avis Europe on the day before the bid was announced was 196.6p.In the FTSE 100, supermarket giant Tesco is weaker after failing to return to sales growth in the UK. In the 13 weeks to 28 May, Tesco's UK like-for-like sales excluding petrol and the impact of VAT were down by 0.1% from the same period the previous year, in line with analysts' predictions, having contracted over the previous quarter. Total sales grew by 7% including petrol and VAT.Another FTSE 100 giant, commodity trading giant Glencore, demonstrated the strength of the markets that propelled it straight into the FTSE 100 after its flotation, revealing a 39% rise in revenues over the first quarter in its first interim management statement as a listed company. Its shares are lower too.Drug giant GlaxoSmithKline has taken another step towards increasing its presence in emerging markets, with the acquisition of the remaining 51% interest in a joint venture established in China to develop 'flu vaccines. It paid Shenzhen Neptunus Interlong Bio-Technique £24m for the stake in the joint venture, which is called Shenzhen GSK-Neptunus Biologicals (GSKNB). Glaxo will become the sole owner of the JV after the agreement is approved by the Chinese authorities. Oilfield services firm Wood Group has extended its contract with TAQA Bratani Limited, the energy company that is 51% owned by Abu Dhabi Water and Electricity Authority, for a further five years.AIM-listed asset finance provider to small and medium enterprise (SMEs) 1pm moved up more than 25% after saying it will announce a return to profitability for the full year following improved trading.FTSE 100 - RisersSchroders (SDR) 1,568.00p +2.75%Schroders (Non-Voting) (SDRC) 1,302.00p +2.04%Essar Energy (ESSR) 438.60p +1.50%IMI (IMI) 1,026.00p +1.48%Barclays (BARC) 264.15p +1.46%Weir Group (WEIR) 2,060.00p +1.43%BHP Billiton (BLT) 2,312.50p +1.43%Vedanta Resources (VED) 2,021.00p +1.40%Rio Tinto (RIO) 4,162.50p +1.39%Anglo American (AAL) 2,937.50p +1.28%FTSE 100 - FallersGlencore International (GLEN) 514.00p -1.80%Tesco (TSCO) 402.05p -1.26%Johnson Matthey (JMAT) 1,978.00p -0.70%Imperial Tobacco Group (IMT) 2,043.00p -0.63%Eurasian Natural Resources Corp. (ENRC) 772.00p -0.58%Carnival (CCL) 2,248.00p -0.27%Scottish & Southern Energy (SSE) 1,381.00p -0.22%Admiral Group (ADM) 1,712.00p -0.17%Morrison (Wm) Supermarkets (MRW) 295.40p -0.14%Randgold Resources Ltd. (RRS) 4,744.00p -0.13%FTSE 250 - RisersAvis Europe (AVE) 310.80p +58.09%AZ Electronic Materials SA (WI) (AZEM) 318.40p +3.44%Howden Joinery Group (HWDN) 109.20p +2.34%Regus (RGU) 104.70p +2.25%Chemring Group (CHG) 669.00p +2.14%Helical Bar (HLCL) 260.00p +2.12%Cookson Group (CKSN) 663.00p +2.08%Stobart Group Ltd. (STOB) 140.00p +2.04%Elementis (ELM) 161.10p +1.90%Sports Direct International (SPD) 228.20p +1.88%FTSE 250 - FallersLamprell (LAM) 348.00p -9.14%Centamin Egypt Ltd. (CEY) 113.50p -2.24%Telecom Plus (TEP) 603.00p -1.71%Kofax (KFX) 480.00p -1.44%Punch Taverns (PUB) 71.50p -1.38%Berendsen (BRSN) 491.90p -1.03%Exillon Energy (EXI) 415.10p -1.03%Scottish Inv Trust (SCIN) 495.30p -0.90%African Barrick Gold (ABG) 402.90p -0.76%BH Global Ltd. GBP Shares (BHGG) 1,093.00p -0.64%
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.